Consumption of dietary Monounsaturated fat and cardiovascular disease.

Monounsaturated fat and total cardiovascular disease (CVD).

Results: Data about the relation between monounsaturated fat and total CVD was provided by 4 cohorts, including 2,456 cases.
No significant associations were found. RR's were available from 3 cohorts. The average RR = 0.95.
Effect modification: No effect modification was suggested by the limited data.
Subjects with prevalent disease: One cohort included women with type 2 diabetes only (Tanasescu M [13]). No significant association was found.

Conclusion: No associations were found. No evidence was found for an association between monounsaturated fat consumption and total cardiovascular disease.

Prospective studies of dietary monounsaturated fat and total cardiovascular disease:
AuthorCohort nameCasesEnd pointRelative Risk (RR)
45) Houston DK (2010)The Health ABC Study203RiskHR = 1.07 (0.64-1.79; P = 0.76).
32) Laaksonen DE (2005)The Kuopio Ischaemic Heart Disease Risk Factor Study78MortalityNo significant association.
31) Leosdottir M (2007)The Malmö Diet and Cancer Study973 men, and

583 women
RiskMen: HR = 0.94 (0.72-1.22; P = 0.7).

Women: HR = 1.05 (0.74-1.48; P = 0.8).
13) Tanasescu M (2004)The Nurses' Health Study619RiskRR = 0.84 (0.53-1.34; P = 0.56).
Total number of cases: 2,456Average RR = 0.95

Monounsaturated fat and coronary heart disease (CHD).

Results:
Coronary heart disease risk: Data was provided by 13 cohorts, including 6,445 cases.
Significant protective effects were found in 2 cohorts (Pietinen P [19], Corella D [44]), though the RR - but not the trend - was significant in the first cohort. Significantly increased risks were found in subgroups of 2 other cohorts (Posner BM [5], Esrey KL [18]). RR's were available from only 6 cohorts. The average RR = 0.90.
Coronary heart disease mortality: Data was provided by 9 cohorts, including 1,429 cases.
A significantly increased risk was found in one subcohort (Esrey KL [18]), but nonsignificant protective effects were found in 3 (sub)cohorts (Kromhout D [7], Pietinen P [19], Xu J [35]). RR's were available from only 4 cohorts. The average RR = 0.87.
Effect modification:

  • Risks were lower among subjects aged ≥ 60 compared to subjects aged < 60 in 4 cohorts, but these were all of very small size (Posner BM [5], Esrey KL [18], Jakobsen MU [29], Xu J [35]). No effect modification was found by age in another cohort, which was of large size (Oh K [13]).
  • No significant effect modification was found by BMI (Oh K [13]), smoking, hypertension, or serum cholesterol (Knekt P [15]).

Subjects with prevalent disease: No data was found.

Conclusion: Inconsistent findings were done. Inconclusive evidence was found for an association between consumption of dietary monounsaturated fat and coronary heart disease. Limited evidence was found for effect modification by age.

Prospective studies of dietary monounsaturated fat and coronary heart disease risk:
AuthorCohort nameCasesEnd pointRelative Risk (RR)
44) Corella D (2010)The Spanish part of the EPIC Study534RiskA significant protective effect (P = 0.002).
35) Xu J (2006)The Strong Heart Study403RiskHR = 1.09 (0.80-1.48; P = 0.64).
31) Leosdottir M (2007)The Malmö Diet and Cancer Study908

(Not defined for men vs women)
RiskMen: HR = 0.87 (0.63-1.21; P = 0.4).

Women: HR = 1.06 (0.65-1.71; P = 1.0).
29) Jakobsen MU (2004)4 Danish cohorts228 men, and

98 women
RiskMen: HR = 1.05 (0.83-1.33).

Women: HR = 1.25 (0.85-1.84).
19) Pietinen P (1997)The ATBC Study1,399RiskRR = 0.82 (0.69-0.99; P = 0.19).
18) Esrey KL (1996)The Lipid Research Clinics Prevalence Follow-Up Study52 aged < 60, and

40 aged ≥ 60
MortalityAged < 60: RR = 1.08 (1.01-1.16; P = < 0.05).

Aged ≥ 60: RR = 1.00 (0.91-1.08).
16) Kromhout D (1995)No cohort name defined58MortalityNo significant association.
15) Knekt P (1994)The Finnish Mobile Clinic Health Cohort244MortalityNo significant association.
13) Oh K (2005)The Nurses' Health Study1,766RiskRR = 0.82 (0.62-1.10; P = 0.19).
7) Kromhout D (1984)The Zutphen Study30MortalityA nonsignificant protective effect (P = 0.094).
5) Posner BM (1991)The Framingham Study99 aged < 56, and

114 aged ≥ 56
RiskAged < 56: RR = 0.64 (0.47-0.88) for low vs high consumption.

Aged ≥ 56: RR = 0.99 (0.77-1.27) for low vs high consumption.
5) Gordon T (1981)The Puerto Rico Heart Health Program163RiskNo significant association.
3) McGee DL (1984)The Honolulu Heart Program309RiskNo significant association.
Total number of cases: 6,445Average RR = 0.90


Prospective studies of dietary monounsaturated fat and coronary heart disease mortality:
AuthorCohort nameCasesEnd pointRelative Risk (RR)
35) Xu J (2006)The Strong Heart Study46 aged < 60, and

92 aged ≥ 60
CHDAged < 60: HR = 2.88 (0.59-14.21; P = 0.13).

Aged ≥ 60: HR = 0.54 (0.27-1.06; P = 0.07).
19) Pietinen P (1997)The ATBC Study635CHDRR = 0.73 (0.56-0.95; P = 0.06).
18) Esrey KL (1996)The Lipid Research Clinics Prevalence Follow-Up Study52 aged < 60, and

40 aged ≥ 60
CHDAged < 60: RR = 1.08 (1.01-1.16; P = < 0.05).

Aged ≥ 60: RR = 1.00 (0.91-1.08).
16) Kromhout D (1995)No cohort name defined58CHDNo significant association.
15) Knekt P (1994)The Finnish Mobile Clinic Health Cohort244CHDNo significant association.
7) Kromhout D (1984)The Zutphen Study30CHDA nonsignificant protective effect (P = 0.094).
5) Gillman MW (1997)The Framingham Study83CHDRR = 1.01 (0.95-1.08).
5) Gordon T (1981)The Puerto Rico Heart Health Study71CHDNo association.
5) Gordon T (1981)The Honolulu Heart Study78CHDNo association.
Total number of cases: 1,429Average RR = 0.87
Prospective studies of dietary monounsaturated fat and coronary heart disease among men and women. Stratified by age:
AuthorCohort nameCasesEnd pointRelative Risk (RR) among subjects aged < 60Relative Risk (RR) among subjects aged ≥ 60
35) Xu J (2006)The Strong Heart Study46 aged < 60, and

92 aged ≥ 60
RiskHR = 2.88 (0.59-14.21; P = 0.13).HR = 0.54 (0.27-1.06; P = 0.07).
29) Jakobsen MU (2004)4 Danish cohortsNot definedRiskMen: HR = 1.47 (0.92-2.37).

Women: HR = 2.98 (1.38-6.44).
Men: HR = 0.95 (0.73-1.24).

Women: HR = 1.03 (0.68-1.57).
18) Esrey KL (1996)The Lipid Research Clinics Prevalence Follow Up Study52 aged < 60, and

40 aged ≥ 60
MortalityRR = 1.08 (1.01-1.16; P = < 0.05).RR = 1.00 (0.91-1.08).
5) Posner BM (1991)The Framingham Study99 < 56, and

114 aged ≥ 56
RiskRR = 0.64 (0.47-0.88) for low vs high consumption.RR = 0.99 (0.77-1.27) for low vs high consumption.

Monounsaturated fat and stroke.

Results:
Total stroke: Data was provided by 5 cohorts, including 1,104 cases.
A significantly increased risk was found in one cohort (Simon JA [12]). No other associations were found. RR's were available from 3 cohorts. The average RR = 0.90.
Ischemic stroke: Data was provided by 6 cohorts, including 1,532 cases.
A significant protective effect was found in one cohort (Gillman MW [5]). No other associations were found. The average RR = 0.98, but this could be calculated from only 3 cohorts.
Hemorrhagic stroke: Data was provided by 3 cohorts, including 308 cases.
No significant effects were found, but all available RR's were well below 1. The average RR = 0.60.
Effect modification: No effect modification was suggested from the limited data.
Subjects with prevalent disease: No data was found.

Conclusion: Few associations were found. No evidence was found for an association between monounsaturated fat consumption and stroke, though the average effect size does not exclude the possibility of a protective effect against hemorrhagic stroke.

Prospective studies of dietary monounsaturated fat and total stroke:
AuthorCohort nameCasesEnd pointRelative Risk (RR)
20) Ross RK (1997)No cohort name defined245MortalityRR = 1.2 (0.8-1.7).
13) He K (2003)The Health Professionals Follow Up Study455 ischemic stroke, and

125 hemorrhagic stroke
RiskIschemic stroke: RR = 1.00 (0.58-1.70; P = 0.85).

Hemorrhagic stroke: RR = 0.68 (0.24-1.96; P = 0.40).
12) Simon JA (1995)The Multiple Risk Factor Intervention Trial96RiskA significantly increased risk (P = < 0.05).
9) Seino F (1997)The Shibata Study141RiskRR = 0.28 (0.05-1.54; P = 0.64).
7) Keli SO (1994)The Zutphen Study42RiskNo significant association.
Total number of cases: 1,104Average RR = 0.90


Prospective studies of dietary monounsaturated fat and ischemic stroke:
AuthorCohort nameCasesEnd pointRelative Risk (RR)
41) Boden-Albala B (2009)The Northern Manhattan Study142RiskNo significant association.
31) Leosdottir M (2007)The Malmö Diet and Cancer Study648

No data for men vs women
RiskMen: HR = 0.82 (0.53-1.26; P = 0.6).

Women: HR = 0.96 (0.59-1.56; P = 0.9).
30) Sauvaget C (2004)The Adult Health Study60MortalityRH = 0.90 (0.45-1.82; P = 0.78).
25) Iso H (2003)No cohort name defined166RiskNo significant association.
13) He K (2003)The Health Professionals Follow Up Study455RiskRR = 1.00 (0.58-1.70; P = 0.85).
5) Gillman MW (1997)The Framingham Heart Study61RiskRR = 0.87 (0.81-0.94).
Total number of cases: 1,532Average RR = 0.98


Prospective studies of dietary monounsaturated fat and hemorrhagic stroke:
AuthorCohort nameCasesEnd pointRelative Risk (RR)
25) Iso H (2003)No cohort name defined68 intraparenchymal hemorrhage, and

41 subarachnoid hemorrhage
RiskIntraparenchymal hemorrhage: RR = 0.53 (0.24-1.16; P = 0.10).

Subarachnoid hemorrhage: No significant association.
13) He K (2003)The Health Professionals Follow Up Study125Haemorrhagic stroke riskRR = 0.68 (0.24-1.96; P = 0.40).
13) Iso H (2001)The Nurses' Health Study74Intraparenchymal hemorrhage riskRR = 0.53 (0.25-1.12; P = 0.13).
Total number of cases: 308Average RR = 0.60.